Garth Sutherland, Adherium CEO & Founder, selected as a Speaker and author at the upcoming meeting, RDD Europe 2017 to be held April 25-28, 2017, at Palais des Congres d’Antibes, Nice (Antibes), France. Link here Garth will present on Thursday, April 27, during Session 3: Can Connected Devices Improve Respiratory Outcomes? 9.30 a.m. ‘Track and Remind’: Can […]
A record number of people gathered across Auckland, Christchurch and Wellington to hear the finalists announced for the 2017 NZ Hi-Tech Awards. – link here Entries this year came from as far afield as Kaitaia and Invercargill which have resulted in a record number of entries being received, up 30% on last year. Wayne Norrie, […]
Monday, March 27, 2017 4:11 pm EDT – Link here SAN DIEGO EmailPDFPrintRSS PUBLIC COMPANY INFORMATION: NYSEMKT: APHB “The growing incidence of antibiotic-resistant bacterial infections is a major health threat that is recognized by governments and health authorities around the world” SAN DIEGO–(BUSINESS WIRE)–AmpliPhi Biosciences Corporation (NYSE MKT: APHB), a global leader in the development […]
Valencia, CA, USA, Perth, Australia and London, United Kingdom, 23 March 2017 — Link here Avita Medical Limited (ASX:AVH; OTCQX:AVMXY), a regenerative medicine company focused on the treatment of wounds and skin defects, today announced that Adam Kelliher, Avita’s Chief Executive Officer will present at the 16th Annual Needham Healthcare Conference on 4 April 2017. […]
Valencia, CA, USA, Perth, Australia and Cambridge, United Kingdom, 16 March 2017 — Link here Avita Medical Limited (ASX:AVH; OTCQX:AVMXY), a regenerative medicine company focused on the treatment of wounds and skin defects, today announced that it has received a Research and Development Tax Incentive cash rebate from the Australian Tax Office of A$974,908 for […]
Clinical data collected from final patient, completing trial • Company plans PMA submission upon receipt of shelf-life stability data • PMA decision anticipated during the 2nd calendar quarter of 2018 Valencia, CA, USA, Perth, Australia and Cambridge, United Kingdom, 7 March 2017 — link here Avita Medical Limited (ASX:AVH; OTCQX:AVMXY), a regenerative medicine company focused […]
U.S. FDA Approves increased Compassionate Use Patient Cases and Sites for ReCell® in Life-Threatening Injuries • Up to 48 patients can now be treated at 15 US burnscenters • Increased use of ReCell® device by US surgeons under the Compassionate Use dispensations • Latest FDA approval separate to approval earlier in the month for Continued […]
CEO Shareholder Letter and Quarterly Report Dear Shareholder, link here As we conclude another quarter, it’s appropriate that I bring you, our owners, up-to-date on the progress Avita has made in recent months. US Approval Program Update The big goal that our team is working towards is entry to the US market, and I am […]
Thursday, November 10, 2016 5:27 pm EST – link here SAN DIEGO EmailPDFPrintRSS PUBLIC COMPANY INFORMATION: NYSEMKT: APHB US03211P1030 “AmpliPhi has made tremendous progress this quarter, demonstrated by the announcement of topline data from clinical trials of both of our lead development programs, including the first U.S.-based trial of AB-SA01” SAN DIEGO–(BUSINESS WIRE)–AmpliPhi Biosciences Corporation […]
CATEGORY: Featured Thursday, November 17, 2016 8:45 am EST – link here SAN DIEGO EmailPDFPrintRSS PUBLIC COMPANY INFORMATION: NYSEMKT: APHB US03211P1030 SAN DIEGO–(BUSINESS WIRE)–AmpliPhi Biosciences Corporation (NYSEMKT:APHB), a biotechnology company focused on the discovery, development and commercialization of novel phage therapeutics, today announced the pricing of an underwritten public offering of 5,335,000 shares of its […]